“Prostate Cancer Diagnostics and Therapy Market” report 2019-2024 provides detailed summary of company competition, market demand, regional forecast, marketing price and new investment feasibility analysis is included of Prostate Cancer Diagnostics and Therapy market. It also covers approximate CAGR, key-players, scope of the report, regional analysis, major market factors of Prostate Cancer Diagnostics and Therapy market, reasons of buying this report and complete TOC of report.
Request a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14244650
There are 4 key segments covered in this Prostate Cancer Diagnostics and Therapy Systems Market report:
- Competitor segment
- Product type segment
- End-use/application segment
- Geography segment
Prostate Cancer Diagnostics and Therapy Market by Key Players:
Enquire Before Purchasing this Report https://www.industryresearch.co/enquiry/pre-order-enquiry/14244650
Scope of the Report:
Key Market Trends:
The Prostate-specific Antigen (PSA) Testing Segment is Expected to Grow at Rapid Pace.
Prostate-specific Antigen (PSA) is a protein produced by prostate cells. Therefore, the PSA test is performed to diagnose prostate cancer (PCa) in men and for follow-up post treatment to check if the cancer relapses. PSA testing is an important tool for detecting prostate cancer, which measures the level of PSA in a man’s blood. Medicare and several private insurers provide coverage for an annual PSA test for all Medicare-eligible men aged 50 and older. The PSA testing is gaining popularity among clinicians and hospitals, owing to the increasing number of people being affected by prostate cancer. It has more market value in the countries with high prevalence rate (Western) and low prevalence rate (Asian), as PSA is used globally for the early detection/screening of prostate cancer.
PSA testing is anticipated to reduce the likelihood of death from prostate cancer. Refinements of the prostate-specific antigen (PSA) test have been developed to reduce the number of false positive results. Therefore, due to the rising prevalence of prostate cancer, the market is expected to witness high growth rate, over the forecast period.
United States is Expected to Retain the Largest Market Share During the Period of Forecast.
Prostate cancer is considered as one of the most common cancers among American men, and more than 60% of all prostate cancers are diagnosed in men older than 65. According to the American Cancer Society’s, 2019, there are about 174,650 new cases of prostate cancer accounting for 31,620 deaths. Hence, it is considered to have an early diagnosis of the condition. In case of the treatment, the early stages of prostate cancer are treated by radiation therapy and for the late stages, where it has spread beyond the prostate gland, hormone therapy, chemotherapy, and or immunotherapy treatments, are recommended. In the case of benign prostatic hyperplasia (BPH), resectoscopy is the major treatment procedure. Zytiga and Xtandi are the major therapeutics that are used for treatment. Zytiga is approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC). With promising pipeline drugs, such as Apalutamide, the market of therapeutics is expected to increase.
Purchase this Report (Price 4250 USD for single user license) https://www.industryresearch.co/purchase/14244650
Prostate Cancer Diagnostics and Therapy Market Covers Following Points in TOC:
- Chapter 1: Prostate Cancer Diagnostics and Therapy Market Definition
- Chapter 2: Research Methodology of Prostate Cancer Diagnostics and Therapy Market
- Chapter 3: Prostate Cancer Diagnostics and Therapy Market Executive Summary
- Chapter 4: Prostate Cancer Diagnostics and Therapy Market Overview Includes Current Market Scenario, Porter’s Five Forces Analysis, Bargaining Power of Suppliers and Consumers, Threat of New Entrants and Substitute Product and Services
- Chapter 5: Market Dynamics Covers Drivers, Restraints, Opportunities and Challenges
- Chapter 6: Prostate Cancer Diagnostics and Therapy Market Segmentation by Types, End-User, and Applications Forecast to 2024
- Chapter 7: Prostate Cancer Diagnostics and Therapy Market Segmentation by Geographical Regions
- Chapter 8: Competitive Landscape of Prostate Cancer Diagnostics and Therapy Market Includes Mergers & Acquisition Analysis, Agreements, Collaborations, and Partnerships, New Products Launches
- Chapter 9: Key Players for Prostate Cancer Diagnostics and Therapy Market
About Industry Research:
Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.
Name: Ajay More
Phone: US +14242530807/ UK +44 20 3239 8187
Email: [email protected]earch.co